Please use this identifier to cite or link to this item: https://ptsldigital.ukm.my/jspui/handle/123456789/576812
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHishar H (UPM)
dc.contributor.authorR. Price
dc.contributor.authorFathinul Fikri A. S (UPM)
dc.contributor.authorEddie Lau W. F
dc.contributor.authorAssunta C
dc.contributor.authorA. J. Nordin (UPM)
dc.date.accessioned2023-11-06T02:08:11Z-
dc.date.available2023-11-06T02:08:11Z-
dc.identifier.issn0128-7680
dc.identifier.otherukmvital:82465
dc.identifier.urihttps://ptsldigital.ukm.my/jspui/handle/123456789/576812-
dc.descriptionDevelopment of the positron emission tomography (PET) diagnostic radiopharmaceutical (18F)fluoro-2-deoxy-D-glucose (18F-FDG) subsequently facilitated the discovery and clinical evaluation of several new tracers as imaging markers for cancer. While 18F-FDG is a widely employed marker for enhanced intracellular glycolysis and metabolic function, one of the newer tracers, (18F)-3’-fluoro-3’ deoxythymidine (18F-FLT), has been developed as a biomarker for cell proliferation. In this review, the potential of 18F-FLT as a biomarker for cancer imaging is discussed.
dc.language.isoen
dc.publisherUniversiti Putra Malaysia
dc.relation.haspartPertanika Journals
dc.relation.urihttp://www.pertanika.upm.edu.my/regular_issues.php?jtype=2&journal=JST-24-1-1
dc.subjectF-FLT
dc.subject18 F-FDG
dc.subjectPositron Emission Tomography (PET)
dc.subjectCellular proliferation
dc.titlePotential of 3’-fluoro-3’ deoxythymidine as a cellular proliferation marker in pet oncology examination
dc.typeJournal Article
dc.format.volume24
dc.format.pages41-52
dc.format.issue1
Appears in Collections:Journal Content Pages/ Kandungan Halaman Jurnal

Files in This Item:
File Description SizeFormat 
ukmvital_82465+Source01+Source010.PDF417.61 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.